Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,200.90
-21.10 (-1.73%)
Jan 28, 2026, 11:00 AM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 127.84 billion as of January 27, 2026. Its market cap has decreased by -43.76% in one year.
Market Cap
127.84B
Enterprise Value
124.54B
Revenue
11.25B
Ranking
n/a
PE Ratio
39.56
Stock Price
1,200.90
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 127.84B, an increase of 29.61%. That is a compound annual growth rate of 11.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 127.84B | -9.19% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 592.65B |
| Anthem Biosciences | 341.96B |
| OneSource Specialty Pharma | 164.13B |
| Blue Jet Healthcare | 75.02B |
| Supriya Lifescience | 57.63B |
| Zota Health Care | 40.27B |
| Dishman Carbogen Amcis | 32.82B |
| Panacea Biotec | 22.30B |